Long COVID causes persistent symptoms affecting numerous individuals. Enoxaparin, a low-molecular-weight heparin, may alleviate these symptoms by thinning blood, reducing microclots, enhancing oxygen delivery, and combating inflammation. Early studies suggest potential benefits for patients with vascular dysfunction, although more extensive clinical trials are necessary to confirm effectiveness and safety.
Long Covid Journey 